For research use only. Not for therapeutic Use.
Dianemycin（Cat No.:I019646）is a potent antimicrobial agent used in the treatment of bacterial infections. It belongs to the macrolide class of antibiotics and works by inhibiting bacterial protein synthesis, specifically targeting the 50S ribosomal subunit. Dianemycin exhibits broad-spectrum activity against a variety of Gram-positive and Gram-negative bacteria, making it valuable in clinical settings. Due to its specific mechanism of action, it is often utilized for infections resistant to other antibiotic classes. Dianemycin is under investigation for its potential applications in treating multi-drug-resistant bacterial strains.
| Catalog Number | I019646 |
| CAS Number | 35865-33-9 |
| Molecular Formula | C₄₇H₇₈O₁₄ |
| Purity | ≥95% |
| Target | Bacterial; Antibiotic |
| Storage | Store at -20°C |
| IUPAC Name | (E,2S,4R,8S)-8-[(2S,5R,7S,8R,9R)-7-hydroxy-2-[(2R,4S,5S,7R,9S,10R)-2-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-9-[(2S,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-4,10-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-2,4,6-trimethyl-5-oxonon-6-enoic acid |
| InChI | InChI=1S/C47H78O14/c1-24(40(50)25(2)18-28(5)43(51)52)17-26(3)41-31(8)34(49)22-45(59-41)16-15-44(11,61-45)38-21-36(56-39-14-13-35(54-12)33(10)55-39)32(9)47(58-38)30(7)20-37(57-47)42-27(4)19-29(6)46(53,23-48)60-42/h17,25-39,41-42,48-49,53H,13-16,18-23H2,1-12H3,(H,51,52)/b24-17+/t25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35+,36+,37-,38-,39-,41-,42+,44+,45-,46+,47+/m1/s1 |
| InChIKey | FELYAZAWTURXNF-KWJIWYEDSA-N |
| SMILES | C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)O)C)O)C)O[C@@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C |
| Reference | [1]. Liu T, et al. Mechanism of thioesterase-catalyzed chain release in the biosynthesis of the polyether antibiotic Nanchangmycin. Chem Biol. 2008 May;15(5):449-58.<br>[2]. Rausch K, et al. Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus. Cell Rep. 2017 Jan 17;18(3):804-815. |
